All imports of areas, permission to produce schools of nuclear power… Iod production GMP permission
Four companies including Nuclear Institute of Nuclear Power and SK Biopharm
Image enlargement
[과기정통부 제공. 재판매 및 DB 금지]
(Seoul = Yonhap News) Reporter Cho Seung-han = The road to produce and supply and supply the cancer treatment radiation, which had difficulty in supply and demand due to the import of imports, was opened in Korea.
The Ministry of Science and ICT announced on the 22nd that the Korea Atomic Energy Academy has established the first production base in Korea by obtaining a license for cyclotron (particle accelerator) -based actinum production from the Nuclear Safety Committee on the 12th.
Radiation Seongdong Plant is a substance that can be used for treatment or diagnosis by releasing radiation. Adding a target ligand, a substance induced to bind to cancer cells, can be used as a radioactive drug.
Actinum is mainly used for treating nerve endocrine cancer and prostate cancer patients, but depends on imports, so patients had to be treated abroad except for some clinical research.
Nuclear schools are produced by shooting and chemically separating radioactive vaguity in radioactive radium (RA-226).
In the case of radioactive iodine for thyroid cancer treatment, which has recently been suspended overseas, the Korea Atomic Energy Research Institute was approved by the Korea Food and Drug Administration last year and received a GMP item permits, and the Ministry of Technology and Technology explained that the research and supply system using ‘Hanaro‘ for the research reactor.
The Ministry of Science and Technology held a field meeting to promote the development of medical isotopes and radioactive drugs at the Nuclear Power Academy in Nowon -gu, Seoul to discuss the domestic supply system of radioactive drugs with radioactive drug companies and nuclear medicine experts.
In the meeting, Kim Yong -kyun, vice chairman of the Korea Radiation Promotion Association, proposed a national level of supply and demand management system for core isotopes, saying that the actinum and iodine were considered to be the first priority requirements for the localization.
After the meeting[326030]Saehan Industry, Selvion[308430]FutureChem[220100] The company has signed an MOU with four radioactive drug companies to form the Alpha New Pharmaceutical Research Council.
Through this agreement, they decided to jointly promote the development of therapeutic drugs, regulations improvement proposals using alpha particle discharge elements such as Actinum and Astatin (AT-211), and discovering the national R & D tasks.
Lee Chang -yun, the first vice minister of the Ministry of Science and Technology, said that the Aktinium and iodine will make efforts to supply it to Korea this year, and the government will actively support 100% self -sufficiency, including building infrastructure infrastructure and expanding radioactive drug development.
shjo@yna.co.kr
Report is KakaoTalk OKJEBO
Unauthorized reproduction-No redistribution, AI learning and utilization>
May 22, 2025 Songgo 13:00
